What is Merrell Dow Pharmaceuticals, Inc. in the Epstein files?

Merrell Dow Pharmaceuticals, Inc. appears only as part of a legal citation to the Supreme Court case Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993), which established standards for expert testimony in federal courts. The company itself has no connection to Jeffrey Epstein or Ghislaine Maxwell.

Why is Merrell Dow Pharmaceuticals mentioned in Maxwell's trial documents?

Defense attorneys cited the Daubert v. Merrell Dow Pharmaceuticals case when filing motions to exclude the government's expert witness testimony under Federal Rule of Evidence 702. This is a standard legal reference used in evidentiary challenges, not an indication of any relationship with the pharmaceutical company.

What was the Daubert v. Merrell Dow Pharmaceuticals case about?

The 1993 Supreme Court case established the 'Daubert Standard' for evaluating scientific expert testimony in federal courts. The case involved allegations that Merrell Dow's drug Bendectin caused birth defects. The ruling created guidelines for judges to assess whether expert scientific testimony is reliable and relevant, and is now routinely cited in federal litigation involving expert witnesses.

What is Merrell Dow Pharmaceuticals, Inc. in the Epstein files?

Merrell Dow Pharmaceuticals, Inc. appears only as part of a legal citation to the Supreme Court case Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993), which established standards for expert testimony in federal courts. The company itself has no connection to Jeffrey Epstein or Ghislaine Maxwell.

Why is Merrell Dow Pharmaceuticals mentioned in Maxwell's trial documents?

Defense attorneys cited the Daubert v. Merrell Dow Pharmaceuticals case when filing motions to exclude the government's expert witness testimony under Federal Rule of Evidence 702. This is a standard legal reference used in evidentiary challenges, not an indication of any relationship with the pharmaceutical company.

What was the Daubert v. Merrell Dow Pharmaceuticals case about?

The 1993 Supreme Court case established the 'Daubert Standard' for evaluating scientific expert testimony in federal courts. The case involved allegations that Merrell Dow's drug Bendectin caused birth defects. The ruling created guidelines for judges to assess whether expert scientific testimony is reliable and relevant, and is now routinely cited in federal litigation involving expert witnesses.

Back to People & Entities

Merrell Dow Pharmaceuticals, Inc.

Organization

Total Mentions

Documents

Connected Entities

Organization referenced in documents

Merrell Dow Pharmaceuticals, Inc. appears in the Epstein files exclusively as a legal citation in court documents from Ghislaine Maxwell's trial, not as an entity connected to the case.

All four mentions reference the landmark Supreme Court case Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which established the standard for admitting expert testimony in federal courts. The company is cited in legal motions to exclude expert witnesses under Federal Rule of Evidence 702, specifically in documents discussing evidentiary standards for Dr. Lisa Rocchio's testimony. Merrell Dow Pharmaceuticals was a pharmaceutical company (formed in 1980 when Dow Chemical acquired Merrell's prescription drug division, later merged into Marion Merrell Dow in 1989, and eventually acquired by Hoechst AG in 1995) that became famous as the defendant in the Daubert case involving the drug Bendectin and alleged birth defects.

Key Highlights

•All mentions are legal citations to Daubert v. Merrell Dow Pharmaceuticals, Inc., not references to the company itself
•The citations appear in defense motions to exclude expert testimony in Maxwell's trial
•The company has no substantive connection to Epstein, Maxwell, or the underlying case—it's simply part of a standard legal citation

Frequently Asked Questions

Books for Further Reading

Perversion of Justice: The Jeffrey Epstein Story

Julie K. Brown

Investigative journalism that broke the Epstein case open

Filthy Rich: The Jeffrey Epstein Story

James Patterson

Bestselling account of Epstein's crimes and network

Relentless Pursuit: My Fight for the Victims of Jeffrey Epstein

Bradley J. Edwards

Victims' attorney's firsthand account

Document Mentions (8)

EFTA00016471 - EFTA00016481

1 mention

ense's motion to exclude the Government's expert witness, Dr. Lisa Rocchio, pursuant to Federal Rule of Evidence 702 and the standard in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). Dkt. No. 386. The Government filed a response brief, Dkt. No. 397, and Defendant filed a reply, Dkt. No. 398. The Court conduc

Page: EFTA00016471 →

EFTA00027649

1 mention

ion under Federal Rule of Evidence 412, Dkt. No. 378, the Defendant's motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other outstanding issues that overlap with these two motions as discussed at the November 1, 2021 confe

Page: EFTA00027649 →